SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
CRIS reported Third Quarter 2026 results. The price and volatility reaction is pending.
CRISearnings

Earnings reactions, page 2

Curis, Inc. (CRIS) Q3 FY2026 earnings

November 14, 2026 · SharpeIQ Research Desk

Reported results

  • Net loss for the third quarter of 2026 was $8.1 million, or $1.94 per share on both a basic and diluted basis, compared to a net loss of $7.7 million, or $9.86 per share, for the third quarter of 2025.
  • Revenues, net were $0 for the third quarter of 2026, compared to $3.2 million for the third quarter of 2025.
  • Research and development expenses were $5.6 million for the third quarter of 2026, compared to $6.4 million for the third quarter of 2025.
  • General and administrative expenses were $3.2 million for the third quarter of 2026, compared to $3.7 million for the third quarter of 2025.
  • Cash and cash equivalents totaled $5.0 million as of September 30, 2026.

Guidance

  • The Company believes that the $5.0 million of existing cash and cash equivalents as of September 30, 2026, together with the net proceeds of approximately $7.5 million from the October 2026 Private Placement, should enable it to fund existing operations into the first quarter of 2027.

Notes

No revenue was reported for the quarter ended September 30, 2026 due to the sale of Erivedge royalties to Oberland in the fourth quarter of 2025.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →